Elephas Biosciences partners Neuberg Diagnostics
Pilot Project between BioCytics and LIDE Biotech
EQL licenses Memprex for Hungarian market through Pharmacenter
Natera to support Phase 1 trial of Kupando's immunotherapy in advanced skin cancers
Galvanize Therapeutics' new Aliya EX System completes first commercial procedures
Laekna's New Drug Application for LAE002 (afuresertib) accepted by China's NMPA
Labcorp receives FDA approval for melanoma companion diagnostic
BeOne Medicines and Revolution Medicines expand oncology collaboration
ValiRx receives notice of intention to grant Cytolytix European patent
Akeso Advances reports first patient dosed in AK146D1 combined with ivonescimab breast cancer study
BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer
Northwest Biotherapeutics signs MOU for collaboration with SPIMACO in Saudi Arabia
Innovent doses first colorectal cancer patient with IBI363/TAK-928 in combination with bevacizumab
Citius Oncology reports growing LYMPHIR adoption and market access